Please login to the form below

Not currently logged in
Email:
Password:

EUSA Pharma

This page shows the latest EUSA Pharma news and features for those working in and with pharma, biotech and healthcare.

AVEO warns EU approval of Fotivda could be at risk

AVEO warns EU approval of Fotivda could be at risk

AVEO’s European licensee EUSA Pharma has been marketing Fotivda (tivozanib) for first- and second-line treatment of adults with renal cell carcinoma (RCC) since November 2017, after the EMA cleared ... While there seemed to be no statistical difference

Latest news

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Pharma deals in March 2015 Pharma deals in March 2015

    The other deal of interest is the re-emergence of EUSA Pharma with products acquired from Jazz Pharmaceuticals. ... investor, Essex Woodlands, has bought back products worth $27m and the EUSA Pharma name from Jazz for an undisclosed amount.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Nigel Brooksby and Dr Tim Corn join the pharma group. Neurocentrx, a UK-based pharmaceutical company, has appointed Nigel Brooksby (pictured right) as non-executive chairman. ... Joining Brooksby is EUSA Pharma’s former chief medical officer Dr Tim Corn

  • EUSA Pharma appoints Rolf Hoffmann to its board EUSA Pharma appoints Rolf Hoffmann to its board

    He most recently worked at Amgen for over a decade. Oncology-focused pharmaceutical group EUSA Pharma has added to its board of directors in the form of Rolf Hoffman. ... Hoffman said: “I have watched EUSA Pharma’s remarkable progress in the three

  • EUSA Pharma adds William Crouse to board of directors EUSA Pharma adds William Crouse to board of directors

    Comes as firm hopes to become global leader in biotechnology. EUSA Pharma has appointed William Crouse to its board of directors. ... Bryan Morton, executive chairman at EUSA Pharma, said: “We have great ambitions for EUSA, and plan to grow our

  • EUSA Pharma appoints Lee Morley as its new chief executive EUSA Pharma appoints Lee Morley as its new chief executive

    EUSA Pharma has appointed Lee Morley to be its new chief executive officer, taking over from Bryan Morton who becomes the UK specialty pharmaceutical company's executive chairman. ... Commenting on the appointments Bryan Morton said: “We are delighted

  • EUSA Pharma founder to chair Glide Pharma EUSA Pharma founder to chair Glide Pharma

    Morton was most recently chief executive at oncology specialist EUSA Pharma – a company he also founded. ... EUSA was sold to Jazz Pharmaceuticals in 2012 for $700m. His other entrepreneurial experience in the industry includes founding Zeneus Pharma,

More from appointments
Approximately 3 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Big wins for Frontera at the 2016 PM Awards

    Two golds:. Caphosol secondary care campaign and the associated sales aid, developed for EUSA Pharma. The materials have been designed around real patient stories to convey the devastation of oral mucositis ... Two silvers:. Caphosol advertisement

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

04 A Healthy Ambience
Creating a Lifeline to the New Digital User...
03 Health Services
How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation...
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...

Infographics